A CROSS-SECTIONAL STUDY OF USE OF IRON SUPPLEMENTS IN CHILDREN WITH ANEMIA

Journal Title: World Journal of Pharmaceutical and Medical Research - Year 2018, Vol 4, Issue 6

Abstract

Objectives: Iron deficiency (ID) is the most common nutritional problem in the world and is the most common cause of childhood anemia. In this study, our aim was to find out about the state of usage of iron preparation, which is distributed free of charge by the Ministry of Health, for the infants between 4-12 months in our country, as well as detecting the awareness degree of families those who are informed about iron-deficiency anemia (IDA), prophylaxis of the drug and to determine the drug’s effectiveness. Methods: It was a cross-sectional survey. The laboratory values from the files of the children aged 1-2 those who visited our hospital’s department of pediatrics, between January 2010 to August 2013, were collected. The survey included families who have children diagnosed with IDA. Questions included about families’ sociodemographic characteristics, the state of the usage of the iron drug, how much information received in terms of the side effects-consumption period and dosage. Results: A total of 139 children were enrolled in our study. While 77.7% of the families who participated stated that (n = 108) iron medicine was prescribed other 43.2% of families stated (n = 60) was prescribed and they were informed about iron pills and IDA. 25.9% of families had received information about drug’s side effects, 74.8% of them had information about period of consumption and 77.7% said they were given information about the drug dose. The average duration of use of iron medicine was 6.98±4.52 (min: 1, max: 24) months. It has been noted that; parent’s education level, mother’s occupation, child’s gender, how the child was born and receiving information about how to use the medicine had no effects on usage of the drug in children. Nevertheless, it has been noticed that, when the families were given proper information the drug use increased and the patients compliance with medications also increased. Conclusion: We believe that, due to frequent diagnosis of anemia in children, prophylaxis iron supplementation should be continued for up to the age of two years.

Authors and Affiliations

Dr. Nayab Fatima

Keywords

Related Articles

AN INTRODUCTION TO CLASSICAL PANCHKARMA

Ayurveda is an ancient science of Indian medical system which not only offers various treatment modalities for the management of different diseases but also possesses literary descriptions regarding different diseases an...

BACTERIOLOGY AND SENSITIVITY PATTERN OF SOME BACTERIAL ISOLATES FROM CLARIAS GARIEPINUS SOLD IN DIFFERENT MARKETS IN PORT HARCOURT METROPOLIS

Bacteriology and sensitivity pattern of some bacterial isolates from Clarias gariepinus sold in different markets in Port Harcourt Metropolis was investigated. Ten C. gariepinus from three markets (Mile 1, Mile 3 and Iwo...

K-RAS-CALMODULIN INTERACTION IN DUCTAL ADENOCARCINOMAS: BRIEF REVIEW

Oncogenic K-Ras has been implicated in most adenocarcinomas and the tumors initiated by K-Ras are known to be more aggressive as compared to the tumors initiated by other isoforms belonging to the Ras superfamily, like N...

TO DETERMINE THE KNOWLEDGE, ATTITUDE, PRACTICES ABOUT HEPATITIS-B VACCINATION AMONG THE FINAL YEAR STUDENTS IN TERTIARY HEALTH CENTRE

Background: Hepatitis B virus poses a health risk to health care workers who are in close proximity to infected individuals. Medical students are particularly high risk group due to the lack of an obligatory vaccination...

AUDIT OF CHILDHOOD TETANUS PATIENTS ADMITTED IN TERTIARY CARE HOSPITAL

Background: Tetanus is an important cause of morbidity and mortality in developing countries though it is rare in developed countries. Childhood tetanus has high mortality and is preventable. Knowledge about the need of...

Download PDF file
  • EP ID EP664713
  • DOI -
  • Views 172
  • Downloads 0

How To Cite

Dr. Nayab Fatima (2018). A CROSS-SECTIONAL STUDY OF USE OF IRON SUPPLEMENTS IN CHILDREN WITH ANEMIA. World Journal of Pharmaceutical and Medical Research, 4(6), 87-92. https://europub.co.uk/articles/-A-664713